Analyst firms · Wells Fargo · TYL

Wells Fargo TYL price target and rating history

Tyler Technologies Inc. (TYL) · Technology

Wells Fargo rates Tyler Technologies Inc. (TYL) Overweight with a $400 price target, as of its latest action on Oct 12, 2026. It has published 5 rating actions on TYL since April 2022, including 2 upgrades and 1 downgrade. Across 9 firms with a TYL price target in the last 12 months, the median target is $460. Wells Fargo's $400 is 13% below that.

Current rating
Overweight
Price target
$400
Median target, all firms
$460
Actions on TYL
5

Wells Fargo price target on TYL

$615$508$4002023202420252026
Wells Fargo price target on TYL, each point a stated target, April 2022 to October 2026.

Every Wells Fargo rating on TYL

How other firms rate TYL

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Wells FargoOverweight$400Oct 12, 2026
Goldman SachsNeutral$345Oct 8, 2026
Piper SandlerOverweight$450Sep 28, 2026
GuggenheimBuy$440Jul 23, 2026
DA DavidsonBuy$460Feb 11, 2026
OppenheimerOutperform$510Jan 23, 2026
StifelBuy$550Jan 8, 2026
BTIGBuy$560Dec 17, 2025
TD CowenBuy$650Dec 12, 2025

Questions about Wells Fargo and TYL

What is Wells Fargo's price target for TYL?
Wells Fargo's latest stated price target for Tyler Technologies Inc. (TYL) is $400, from its action on Oct 12, 2026.
What is Wells Fargo's rating on TYL?
Wells Fargo rates TYL Overweight, a bullish rating, as of Oct 12, 2026.
When did Wells Fargo last change its view on TYL?
On Oct 12, 2026, Wells Fargo upgrades to Overweight from Equal Weight, price target $400.
How does Wells Fargo's TYL target compare with other analysts?
Across 9 firms with a TYL price target in the last 12 months, the median target is $460. Wells Fargo's $400 is 13% below that.

More TYL rating histories

All Wells Fargo ratingsTYL news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.